IP Library Granted Patent US 11,136,376
Granted Patent B2
US 11,136,376 · App. 15/934,055 · Granted Oct 5, 2021

Recombinant immunoglobulin heavy chains comprising a sortase conjugation loop and conjugates thereof

Inventors: Alfred Engel (Weilheim, DE); Pavel Kubalec (Feldafing, DE); Alfons Nichtl (Hohenpeissenberg, DE); Tobias Oelschlaegel (Munich, DE); Rainer Schlecht (Frankfurt am Main, DE)
Assignee: Roche Diagnostics Operations, Inc.
C07K16/00C07K2317/51C07K2317/522C07K2317/524C07K2317/526C07K2317/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,136,376
App. No.
15/934,055
Granted
Oct 5, 2021
Kind
B2
Abstract

The disclosure describes a recombinant immunoglobulin heavy chain comprising a sortase conjugation loop, methods for conjugating and/or labeling such recombinant immunoglobulin heavy chains by use of the enzyme sortase and to the conjugates/labeled products obtained via the method.

Claims (22)

1. A recombinant immunoglobulin heavy chain comprising a VH-domain, a CH1 domain, a hinge region down to the C-terminal most cysteine of the middle hinge region, a sortase conjugation loop, a CH2 domain and a CH3 domain,

wherein the sortase conjugation loop comprises:

a) at least 16 amino acids located between the C-terminal most cysteine of the middle hinge region and the VFX1FPP (SEQ ID NO: 2; wherein X1 is L or I) consensus sequence at the N-terminus of an immunoglobulin heavy chain CH2-domain,

b) a sortase recognition motif of the amino acid sequence LPX1TX2 (SEQ ID NO: 01), wherein X1 can be any amino acid residue and X2 is G or A,

c) N-terminal to the sequence of (b) at least two amino acids, and

d) C-terminal to the sequence of (b) at least 6 amino acids, and

wherein the amino acids C- and N-terminal to the sequence of (b) are not cysteine.

2. The recombinant immunoglobulin heavy chain of claim 1 , wherein said sortase conjugation loop comprises at least 9 amino acids C-terminal to the sequence LPX1TX2 (SEQ ID NO: 01, wherein X1 can be any amino acid residue and X2 is G or A).

3. The recombinant immunoglobulin heavy chain of claim 1 , wherein said sortase conjugation loop comprises at least 5 amino acids N-terminal to the sequence LPX1TX2 (SEQ ID NO: 01, wherein X1 can be any amino acid residue and X2 is G or A).

4. The recombinant immunoglobulin heavy chain of claim 1 , wherein said sortase conjugation loop comprises at least 8 amino acids N-terminal to the sequence LPX1TX2 (SEQ ID NO: 01, wherein X1 can be any amino acid residue and X2 is G or A).

5. The recombinant immunoglobulin heavy chain according to claim 1 , wherein said sortase conjugation loop comprises at least 5 amino acids N-terminal to the sequence LPX1TX2 (SEQ ID NO: 01, wherein X1 can be any amino acid residue and X2 is G or A), and at least 9 amino acids C-terminal to said sequence.

6. The recombinant immunoglobulin heavy chain according to claim 1 , wherein said sortase conjugation loop comprises at least 8 amino acids N-terminal to the sequence LPX1TX2 (SEQ ID NO: 01, wherein X1 can be any amino acid residue and X2 is G or A), and at least 9 amino acids C-terminal to said sequence.

7. The recombinant immunoglobulin heavy chain according to claim 1 , wherein said sortase conjugation loop is at most 50 amino acids long.

8. An antibody comprising at least two recombinant immunoglobulin heavy chains according to claim 1 .

9. An IgG class antibody having two recombinant immunoglobulin heavy chains according to claim 1 .

10. A method for producing a conjugate of a sortase cleavage fragment of a recombinant immunoglobulin heavy chain and a sortase nucleophile comprising incubating

i) the antibody according to claim 7 ,

ii) a compound comprising a sortase nucleophile, and

iii) a polypeptide with sortase activity, thereby cleaving the recombinant antibody heavy chain after the threonine in LPX1TX2 (SEQ ID NO: 01, wherein X1 can be any amino acid residue and X2 is G or A) and conjugating the N-terminus of the sortase nucleophile to said threonine.

11. The method according to claim 10 , wherein the sortase nucleophile comprises a tag of interest and has the formula (Gly) n -tag, wherein n is at least 2.

12. The method according to claim 10 , wherein the sortase nucleophile comprises a tag of interest and has the formula (Gly) n -tag and wherein n is selected from 2, 3, 4, 5 or 6.

13. The method according to claim 10 , wherein the sortase nucleophile comprises a tag of interest and has the formula (Gly) n -tag, wherein n is at most 30.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ENGEL, ALFRED; KUBALEC, PAVEL; NICHTL, ALFONS; OELSCHLAEGEL, TOBIAS; SCHLECHT, RAINER
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 045595/0889 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 045595/0909 →
Priority Claims (1)
EP 15186821 · Sep 25, 2015 · regional
Continuity (2)
Continuation PCTEP2016072529 · Sep 22, 2016
Related Publication 20210009660A1 · Jan 14, 2021